Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

New Canadian Tech Can Detect Influenza Virus

Stockhouse Editorial
1 Comment| March 9, 2022

{{labelSign}}  Favorites
{{errorMessage}}


(Image via Kontrol Energy Corp.)

Operating in the business of smart buildings and cities through IoT, cloud, and SaaS technology, Kontrol Technologies Corp. (CSE: KNR, Forum) reported this week that it had completed initial testing of its BioCloud technology in Japan and has delivered a positive detection of the influenza virus. The initial testing indicates the application of the BioCloud technology for influenza virus.

Testing was provided through a laboratory in Japan and the initial testing was focused on the ability of Kontrol BioCloud to capture aerosolized influenza virus in its proprietary collection chamber. Based on initial testing the BioCloud technology was able to successfully capture the virus.

Each BioCloud unit in operation logs thousands of data points daily in real-time and Kontrol Technologies Corp.’s Chief Executive Officer, Paul Ghezzi explained via a media release on this news that with a growing movement to monitor air quality in buildings with early viral detection systems, BioCloud continues to be well positioned to offer solutions that seek to create safer spaces across the global economy.

Kontrol BioCloud’s President, Gary Saunders added that this technology is based on taking a manual laboratory process and automating that process in real-time, with the goal of monitoring ambient air for early viral detection.

“Since the inception of our technology development we have indicated our intention to be able to detect multiple virus and pathogens as part of overall area safety. We are pleased with the initial positive testing with aerosolized influenza virus.”

Earlier this year, KNR announced that it had expanded its BioCloud technology global footprint with a Japan-based trading company. This business is well-established in Japan and has a 60-year history of large-scale deployment of HVAC and air quality systems.


New to investing in Healthcare? Check out Stockhouse tips on some of our Top Healthcare Stocks.

For more of the latest info on Healthcare stocks, check out the Healthcare Trending News hub on Stockhouse.



{{labelSign}}  Favorites
{{errorMessage}}

Comments

No comments yet. Be first to comment!

Leave a Comment

You must be logged in to be able to post a comment.

Get the latest news and updates from Stockhouse on social media

Follow STOCKHOUSE Today